Today

J&J Financial News

All news where J&J is mentioned

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

Dabur sees early signs of rural recovery, enters talcum powder market

Dabur sees early signs of rural recovery, enters talcum powder market

J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family

J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family

WHO says wider alert on contaminated J&J cough syrup 'likely'

WHO says wider alert on contaminated J&J cough syrup 'likely'

Hygiene brand Pee Safe crosses Rs 100 crore in sales, nears profitability

J&J to pump another $13B into its MedTech business with Shockwave deal

J&J to pump another $13B into its MedTech business with Shockwave deal

Johnson & Johnson to buy Shockwave Medical for $12.5 bln

Johnson & Johnson to buy Shockwave Medical for $12.5 bln

New blood thinners will prevent blood clots without causing bleeding

New blood thinners will prevent blood clots without causing bleeding

Latest J&J talc trial ends with hung jury

Latest J&J talc trial ends with hung jury

Expecting a Market Downturn? Protect Your Portfolio With These Dividend Champions

Expecting a Market Downturn? Protect Your Portfolio With These Dividend Champions

J&J profit edges past Street view after deals delay Stelara competition

J&J profit edges past Street view after deals delay Stelara competition

US FDA requires 'boxed warning' for CAR-T cancer therapies

US FDA requires 'boxed warning' for CAR-T cancer therapies

Investors see 6,700 Percent Gains as J&J Snaps Up Ambrx in Biotech Deal

Investors see 6,700 Percent Gains as J&J Snaps Up Ambrx in Biotech Deal

Feminine hygiene penetration still lower than 30% in India: Pee Safe

Feminine hygiene penetration still lower than 30% in India: Pee Safe

Judge certifies Johnson & Johnson shareholder class action over talc disclosures

Judge certifies Johnson & Johnson shareholder class action over talc disclosures

Johnson & Johnson forecasts as much as 6% sales growth in 2024

Johnson & Johnson forecasts as much as 6% sales growth in 2024

How much time off should you get to mourn? Bosses extend grief leave

How much time off should you get to mourn? Bosses extend grief leave

J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?

J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?

South Africa, Colombia, others are fighting drugmakers over access to TB, HIV drugs

South Africa, Colombia, others are fighting drugmakers over access to TB, HIV drugs

GSK to pay $1 billion for exclusive license to J&J's hepatitis B therapy

GSK to pay $1 billion for exclusive license to J&J's hepatitis B therapy

J&J says DoJ seeking information related to eye products in civil investigation

J&J says DoJ seeking information related to eye products in civil investigation

1
2
3
Next

About Us

Fvbb.com is an aggregator of the latest financial news in your feed. Be the first to know everything concerning financial analyzes, currency, world economy, investments and even much more. The latest financial news from the leading news agencies around the world at one place for your comfort. 300+ information resources are here on our site, that give you the opportunity to save time on search. Just actual news 24/7 non-stop! Stay tuned and we will keep you informed!

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories

Info

For advertisers

Advertising Questions ?

Add news

Add Source

©2024. All rights reserved.

DMCA